Drugs / BMC2012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02803177 | Jul 2016 → Dec 2019 | bone disorder | Goethe University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMC2012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02803177 ↗ |
| Known as | bone marrow-derived mononuclear cells | “BMC2012, Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures” NCT02803177 ↗ |
| Modality | Cell therapy | “Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells” PMID 37995325 ↗ Jan 2024 |
| Route | Other | “Implanted Bone Marrow-derived Mononuclear Cells” NCT02803177 ↗ |